We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Stellar Announces Exclusive Option to License Clostridium Difficile Technology

News   Apr 11, 2012

 
Stellar Announces Exclusive Option to License Clostridium Difficile Technology
 
 
 

RELATED ARTICLES

Two HPV Types Linked to Cervical Cancer Have Declined Since Arrival of the HPV Vaccine

News

An analysis of cervical precancers over a period of seven years showed that two strains of human papillomavirus (HPV) that have been targeted by vaccination since 2006 have declined, accounting for a smaller proportion of cervical disease, according to newly published research.

READ MORE

Paradigm Shift for Design of Universal Vaccines

News

Killer T cells have been identified that can fight all influenza viruses – A, B and C – creating the potential for the development of a world-first universal, one-shot flu vaccine.

READ MORE

Machine Learning Swiftly Analyzes Nanomedicines for Cancer Immunotherapy

News

With their ability to treat a wide a variety of diseases, spherical nucleic acids are poised to revolutionize medicine. But before these digitally designed nanostructures can reach their full potential, researchers need to optimize their various components. A team has developed a direct route to optimize these particles, bringing them one step closer to becoming a viable treatment option for numerous diseases, including cancer.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE